Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kristine C Willett"'
Publikováno v:
American Journal of Therapeutics. 30:e108-e116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4509b877eeff3394bd9944ee7db1cf35
https://doi.org/10.1097/mjt.0000000000001603
https://doi.org/10.1097/mjt.0000000000001603
Publikováno v:
Clinical Medicine Insights: Gastroenterology, Vol 2012, Iss 5, Pp 65-76 (2012)
Externí odkaz:
https://doaj.org/article/c689befaae7441d8af7464555b1894b1
Publikováno v:
American Journal of Therapeutics. 25:e333-e338
BACKGROUND The approval of the oral direct thrombin inhibitor, dabigatran etexilate, gave patients an alternative to oral anticoagulation with warfarin. Like all anticoagulants, the primary adverse event (AE) associated with dabigatran is bleeding. U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a5de2a258b0d90c2c5c05960393598
https://doi.org/10.1097/mjt.0000000000000460
https://doi.org/10.1097/mjt.0000000000000460
Publikováno v:
American Journal of Therapeutics. 24:e763-e769
The purpose of this review is to evaluate the efficacy and safety of ceftazidime/avibactam and ceftolozane/tazobactam in patients with complicated intra-abdominal infections (cIAI), and review eravacycline and other agents in the pipeline for managem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b2ae1d7c86c36973435f3a4df11f460
https://doi.org/10.1097/mjt.0000000000000433
https://doi.org/10.1097/mjt.0000000000000433
Publikováno v:
Journal of Pharmacy Technology. 33:237-244
Objective: To review nivolumab for the treatment of classical Hodgkin lymphoma (cHL). Data Sources: Literature searches were conducted in Medline (1946 to May week 3 2017), EMBASE (1974 to 2017 week 22), and Google Scholar using the terms Hodgkin lym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d74baad4b725819aa892e049a8b8e4e
https://doi.org/10.1177/8755122517716472
https://doi.org/10.1177/8755122517716472
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(21)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c888866ffc74daa7aaa8bb7d5c8386d
https://pubmed.ncbi.nlm.nih.gov/31612929
https://pubmed.ncbi.nlm.nih.gov/31612929
Autor:
Kristine C. Willett, Amanda M. Morrill
Publikováno v:
Therapeutics and Clinical Risk Management
Background The use of direct oral anticoagulants (DOACs) is restricted by the limitations of clinical trials guiding therapy for patients with renal impairment, as many of these trials excluded patients with severe renal impairment. There are current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::213526e979a16b25466b2b5fc907ea87
https://pubmed.ncbi.nlm.nih.gov/28435279
https://pubmed.ncbi.nlm.nih.gov/28435279
Publikováno v:
American Journal of Health-System Pharmacy. 71:1177-1182
Purpose Currently available evidence on the use of daptomycin in pediatric patients is reviewed and evaluated. Summary Although guidelines on the treatment of methicillin-resistant Staphylococcus aureus infections recommend daptomycin for use in pedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd91ccc2ad92346d067f14f4e9307460
https://doi.org/10.2146/ajhp130601
https://doi.org/10.2146/ajhp130601
Publikováno v:
Annals of Pharmacotherapy. 47:1717-1720
To evaluate the appropriate dosing of enoxaparin as a venous thromboembolism (VTE) prophylaxis in hospitalized obese patients.Literature articles were accessed through MEDLINE (1946 to August week 1, 2013) and EMBASE (1980 to 2013 week 33) searches u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff2b25453e9ccaca55f4c08e5d0e0c0
https://doi.org/10.1177/1060028013507902
https://doi.org/10.1177/1060028013507902
Publikováno v:
Annals of Pharmacotherapy. 46:1700-1706
Objective: To evaluate the potential role of exenatide for weight loss in overweight or obese adults without diabetes. Data Sources: PubMed (1946-August 2012) and EMBASE (1974-August 2012) were used to conduct a literature search utilizing the terms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ab898f12651f477c91ee07377f4489
https://doi.org/10.1345/aph.1r372
https://doi.org/10.1345/aph.1r372